• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.支架蛋白NHERF1调节酪氨酸激酶HER2的稳定性和活性。
J Biol Chem. 2017 Apr 21;292(16):6555-6568. doi: 10.1074/jbc.M116.770883. Epub 2017 Feb 24.
2
Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.抑 制 ezrin 导致乳腺癌细胞中 PKCα 介导的 erbb2/HER2 酪氨酸激酶内化。
J Biol Chem. 2019 Jan 18;294(3):887-901. doi: 10.1074/jbc.RA118.004143. Epub 2018 Nov 21.
3
PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer.质膜钙泵2(PMCA2)调节人表皮生长因子受体2(HER2)蛋白激酶的定位和信号传导,并促进HER2介导的乳腺癌。
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E282-90. doi: 10.1073/pnas.1516138113. Epub 2016 Jan 4.
4
NHERF1 Is Required for Localization of PMCA2 and Suppression of Early Involution in the Female Lactating Mammary Gland.NHERF1 对于 PMCA2 的定位和雌性哺乳期乳腺早期退化的抑制是必需的。
Endocrinology. 2019 Aug 1;160(8):1797-1810. doi: 10.1210/en.2019-00230.
5
MAL2 mediates the formation of stable HER2 signaling complexes within lipid raft-rich membrane protrusions in breast cancer cells.MAL2 在富含脂筏的乳腺癌细胞膜突起中介导稳定的 HER2 信号复合物的形成。
Cell Rep. 2021 Dec 28;37(13):110160. doi: 10.1016/j.celrep.2021.110160.
6
HER2 signaling regulates HER2 localization and membrane retention.HER2信号传导调节HER2的定位和膜保留。
PLoS One. 2017 Apr 3;12(4):e0174849. doi: 10.1371/journal.pone.0174849. eCollection 2017.
7
Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.钠/氢交换调节因子1抑制乳腺癌细胞中血小板衍生生长因子信号传导。
Breast Cancer Res. 2008;10(1):R5. doi: 10.1186/bcr1846. Epub 2008 Jan 11.
8
NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.NHERF1,一种新型的与GPER相关的蛋白质,可增强雌激素受体阳性乳腺癌中GPER的稳定性和活性。
Oncotarget. 2016 Aug 23;7(34):54983-54997. doi: 10.18632/oncotarget.10713.
9
The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin.钙泵质膜Ca(2+)-ATP酶2(PMCA2)调节乳腺癌细胞增殖及对阿霉素的敏感性。
Sci Rep. 2016 May 5;6:25505. doi: 10.1038/srep25505.
10
The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.NHERF1 PDZ2结构域调节蛋白激酶A- RhoA - p38介导的乳腺癌细胞中NHE1的激活和侵袭。
Mol Biol Cell. 2007 May;18(5):1768-80. doi: 10.1091/mbc.e06-07-0617. Epub 2007 Mar 1.

引用本文的文献

1
Erbin interacts with NHERF1 and Ezrin to stabilize a membrane ErbB2 signaling complex in HER2-positive breast cancer.在HER2阳性乳腺癌中,Erbin与NHERF1和埃兹蛋白相互作用,以稳定膜上的表皮生长因子受体2信号复合物。
Breast Cancer Res. 2025 May 19;27(1):85. doi: 10.1186/s13058-025-02025-6.
2
Intracellular calcium links milk stasis to lysosome-dependent cell death during early mammary gland involution.细胞内钙将乳汁淤积与早期乳腺退化过程中的溶酶体依赖性细胞死亡联系起来。
Cell Mol Life Sci. 2024 Jan 12;81(1):29. doi: 10.1007/s00018-023-05044-8.
3
Pathophysiological role of ion channels and transporters in HER2-positive breast cancer.离子通道和转运体在 HER2 阳性乳腺癌中的病理生理作用。
Cancer Gene Ther. 2022 Aug;29(8-9):1097-1104. doi: 10.1038/s41417-021-00407-4. Epub 2022 Jan 7.
4
MAL2 mediates the formation of stable HER2 signaling complexes within lipid raft-rich membrane protrusions in breast cancer cells.MAL2 在富含脂筏的乳腺癌细胞膜突起中介导稳定的 HER2 信号复合物的形成。
Cell Rep. 2021 Dec 28;37(13):110160. doi: 10.1016/j.celrep.2021.110160.
5
EGFR Expression in HER2-Driven Breast Cancer Cells.表皮生长因子受体在 HER2 驱动型乳腺癌细胞中的表达。
Int J Mol Sci. 2020 Nov 27;21(23):9008. doi: 10.3390/ijms21239008.
6
Mathematical modeling of drug-induced receptor internalization in the HER2-positive SKBR3 breast cancer cell-line.药物诱导 HER2 阳性 SKBR3 乳腺癌细胞内受体内化的数学建模。
Sci Rep. 2019 Sep 3;9(1):12709. doi: 10.1038/s41598-019-49019-x.
7
A Central Region of NF-κB Essential Modulator Is Required for IKKβ-Induced Conformational Change and for Signal Propagation.NF-κB 必需调节剂的中央区域对于 IKKβ 诱导的构象变化和信号转导是必需的。
Biochemistry. 2019 Jul 2;58(26):2906-2920. doi: 10.1021/acs.biochem.8b01316. Epub 2019 Jun 18.
8
NHERF1 Is Required for Localization of PMCA2 and Suppression of Early Involution in the Female Lactating Mammary Gland.NHERF1 对于 PMCA2 的定位和雌性哺乳期乳腺早期退化的抑制是必需的。
Endocrinology. 2019 Aug 1;160(8):1797-1810. doi: 10.1210/en.2019-00230.
9
Inhibition of ezrin causes PKCα-mediated internalization of erbb2/HER2 tyrosine kinase in breast cancer cells.抑 制 ezrin 导致乳腺癌细胞中 PKCα 介导的 erbb2/HER2 酪氨酸激酶内化。
J Biol Chem. 2019 Jan 18;294(3):887-901. doi: 10.1074/jbc.RA118.004143. Epub 2018 Nov 21.
10
Merlin/ERM proteins regulate growth factor-induced macropinocytosis and receptor recycling by organizing the plasma membrane:cytoskeleton interface.Merlin/ERM 蛋白通过组织质膜-细胞骨架界面来调节生长因子诱导的巨胞饮作用和受体再循环。
Genes Dev. 2018 Sep 1;32(17-18):1201-1214. doi: 10.1101/gad.317354.118. Epub 2018 Aug 24.

本文引用的文献

1
The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.钠氢交换调节因子1的细胞分布由PDZ-I结构域决定,并调节乳腺癌的恶性进展。
Oncotarget. 2016 May 17;7(20):29440-53. doi: 10.18632/oncotarget.8751.
2
A Novel NHERF1 Mutation in Human Breast Cancer Inactivates Inhibition by NHERF1 Protein in EGFR Signaling.人类乳腺癌中一种新型的NHERF1突变使NHERF1蛋白对表皮生长因子受体(EGFR)信号传导的抑制作用失活。
Anticancer Res. 2016 Mar;36(3):1165-73.
3
PMCA2 regulates HER2 protein kinase localization and signaling and promotes HER2-mediated breast cancer.质膜钙泵2(PMCA2)调节人表皮生长因子受体2(HER2)蛋白激酶的定位和信号传导,并促进HER2介导的乳腺癌。
Proc Natl Acad Sci U S A. 2016 Jan 19;113(3):E282-90. doi: 10.1073/pnas.1516138113. Epub 2016 Jan 4.
4
The Mysterious Ways of ErbB2/HER2 Trafficking.ErbB2/HER2 运输的神秘途径。
Membranes (Basel). 2014 Aug 6;4(3):424-46. doi: 10.3390/membranes4030424.
5
ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics.表皮生长因子受体家族:从癌基因发现到基础科学再到基于机制的癌症治疗。
Cancer Cell. 2014 Mar 17;25(3):282-303. doi: 10.1016/j.ccr.2014.02.025.
6
Nuclear NHERF1 expression as a prognostic marker in breast cancer.核 NHERF1 表达作为乳腺癌的预后标志物。
Cell Death Dis. 2013 Nov 7;4(11):e904. doi: 10.1038/cddis.2013.439.
7
Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signaling.乳腺癌衍生的 K172N、D301V 突变可消除 Na+/H+ 交换体调节因子 1 对血小板衍生生长因子受体信号的抑制作用。
FEBS Lett. 2013 Oct 11;587(20):3289-95. doi: 10.1016/j.febslet.2013.08.026. Epub 2013 Sep 5.
8
Plasma membrane calcium ATPases as novel candidates for therapeutic agent development.细胞膜钙 ATP 酶作为治疗药物开发的新候选物。
J Pharm Pharm Sci. 2013;16(2):190-206. doi: 10.18433/j3z011.
9
Hsp90 inhibitors in breast cancer: a systematic review.热休克蛋白 90 抑制剂在乳腺癌中的应用:系统评价。
Breast. 2013 Oct;22(5):569-78. doi: 10.1016/j.breast.2013.06.003. Epub 2013 Jul 17.
10
Application of fusion protein 4D5 scFv-dibarnase:barstar-gold complex for studying P185HER2 receptor distribution in human cancer cells.融合蛋白 4D5 scFv-dibarnase:barstar-gold 复合物在研究人癌细胞 P185HER2 受体分布中的应用。
Biochimie. 2012 Aug;94(8):1833-6. doi: 10.1016/j.biochi.2012.04.011. Epub 2012 Apr 17.

支架蛋白NHERF1调节酪氨酸激酶HER2的稳定性和活性。

The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.

作者信息

Jeong Jaekwang, VanHouten Joshua N, Kim Wonnam, Dann Pamela, Sullivan Catherine, Choi Jungmin, Sneddon W Bruce, Friedman Peter A, Wysolmerski John J

机构信息

From the Section of Endocrinology and Metabolism, Department of Internal Medicine.

Department of Pediatrics, and.

出版信息

J Biol Chem. 2017 Apr 21;292(16):6555-6568. doi: 10.1074/jbc.M116.770883. Epub 2017 Feb 24.

DOI:10.1074/jbc.M116.770883
PMID:28235801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5399107/
Abstract

We examined whether the scaffolding protein sodium-hydrogen exchanger regulatory factor 1 (NHERF1) interacts with the calcium pump PMCA2 and the tyrosine kinase receptor ErbB2/HER2 in normal mammary epithelial cells and breast cancer cells. NHERF1 interacts with the PDZ-binding motif in PMCA2 in both normal and malignant breast cells. NHERF1 expression is increased in HER2-positive breast cancers and correlates with HER2-positive status in human ductal carcinoma (DCIS) lesions and invasive breast cancers as well as with increased mortality in patients. NHERF1 is part of a multiprotein complex that includes PMCA2, HSP90, and HER2 within specific actin-rich and lipid raft-rich membrane signaling domains. Knocking down NHERF1 reduces PMCA2 and HER2 expression, inhibits HER2 signaling, dissociates HER2 from HSP90, and causes the internalization, ubiquitination, and degradation of HER2. These results demonstrate that NHERF1 acts with PMCA2 to regulate HER2 signaling and membrane retention in breast cancers.

摘要

我们研究了支架蛋白钠氢交换调节因子1(NHERF1)在正常乳腺上皮细胞和乳腺癌细胞中是否与钙泵PMCA2以及酪氨酸激酶受体ErbB2/HER2相互作用。在正常和恶性乳腺细胞中,NHERF1均与PMCA2中的PDZ结合基序相互作用。NHERF1在HER2阳性乳腺癌中表达增加,并且与人导管原位癌(DCIS)病变和浸润性乳腺癌中的HER2阳性状态相关,也与患者死亡率增加相关。NHERF1是一种多蛋白复合物的一部分,该复合物在特定的富含肌动蛋白和富含脂筏的膜信号域中包含PMCA2、HSP90和HER2。敲低NHERF1会降低PMCA2和HER2的表达,抑制HER2信号传导,使HER2与HSP90解离,并导致HER2的内化、泛素化和降解。这些结果表明,NHERF1与PMCA2共同作用以调节乳腺癌中的HER2信号传导和膜保留。